Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.46)
# 939
Out of 4,711 analysts
29
Total ratings
44.83%
Success rate
7.9%
Average return
Main Sectors:
Stocks Rated by Chase Knickerbocker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SCPH scPharmaceuticals | Maintains: Buy | $16 → $12 | $3.39 | +253.98% | 2 | Nov 14, 2024 | |
| KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $4.02 | +24.38% | 1 | Nov 14, 2024 | |
| PYPD PolyPid | Initiates: Buy | $10 | $3.22 | +210.56% | 1 | Nov 4, 2024 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $10 → $15 | $12.57 | +19.33% | 3 | Oct 28, 2024 | |
| INDV Indivior | Maintains: Buy | $20 → $16 | $11.66 | +37.22% | 3 | Oct 11, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $65 | $34.22 | +89.95% | 3 | Oct 4, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $17 → $15 | $5.99 | +150.42% | 4 | Aug 14, 2024 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Buy | $14 → $10 | $4.45 | +124.72% | 3 | Aug 9, 2024 | |
| MDXG MiMedx Group | Maintains: Buy | $14 → $12 | $9.10 | +31.87% | 2 | Aug 1, 2024 | |
| CDRO Codere Online Luxembourg | Initiates: Buy | $10 | $7.25 | +37.93% | 1 | Jul 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $11.01 | +63.49% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $10.31 | +123.08% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1 → $1.2 | $0.38 | +215.79% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $7.45 | +181.88% | 1 | Mar 13, 2023 |
scPharmaceuticals
Nov 14, 2024
Maintains: Buy
Price Target: $16 → $12
Current: $3.39
Upside: +253.98%
KORU Medical Systems
Nov 14, 2024
Maintains: Buy
Price Target: $4 → $5
Current: $4.02
Upside: +24.38%
PolyPid
Nov 4, 2024
Initiates: Buy
Price Target: $10
Current: $3.22
Upside: +210.56%
Eton Pharmaceuticals
Oct 28, 2024
Maintains: Buy
Price Target: $10 → $15
Current: $12.57
Upside: +19.33%
Indivior
Oct 11, 2024
Maintains: Buy
Price Target: $20 → $16
Current: $11.66
Upside: +37.22%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $65
Current: $34.22
Upside: +89.95%
Fennec Pharmaceuticals
Aug 14, 2024
Maintains: Buy
Price Target: $17 → $15
Current: $5.99
Upside: +150.42%
Ironwood Pharmaceuticals
Aug 9, 2024
Maintains: Buy
Price Target: $14 → $10
Current: $4.45
Upside: +124.72%
MiMedx Group
Aug 1, 2024
Maintains: Buy
Price Target: $14 → $12
Current: $9.10
Upside: +31.87%
Codere Online Luxembourg
Jul 11, 2024
Initiates: Buy
Price Target: $10
Current: $7.25
Upside: +37.93%
Jun 28, 2024
Initiates: Buy
Price Target: $18
Current: $11.01
Upside: +63.49%
May 9, 2024
Maintains: Buy
Price Target: $22 → $23
Current: $10.31
Upside: +123.08%
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.38
Upside: +215.79%
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $7.45
Upside: +181.88%